The octapeptide hormone angiotensin II is one of the most studied peptides with aim designing and synthesizing non-peptide mimetics for oral administration. To achieve this, cyclizations at different positions within peptide molecule has been a useful strategy to define active conformation. These studies on led discovery Sarmesin, type antagonist, breakthrough mimetic Losartan, first in series ...